Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial.

Gossger, Nicoletta;Snape, Matthew D;Yu, Ly-Mee;Finn, Adam;Pollard, Andrew J;et.al.
(2012) JAMA : the journal of the American Medical Association —

Files

pdfdocument.pdf
  • Restricted Access
  • Adobe PDF
  • 251.99 KB
Request a copy

Details

Authors
  • Gossger, Nicoletta
    Author
  • Snape, Matthew D
    Author
  • Yu, Ly-Mee
    Author
  • Finn, Adam
    Author
  • Sokal, EtienneUCLouvain
    Author
  • Pollard, Andrew J
    Author
Show more
Abstract
clinicaltrials.gov Identifier: NCT00721396.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Gossger, N., Snape, M. D., Yu, L.-M., Finn, A., Bona, G., Esposito, S., Principi, N., Diez-Domingo, J., Sokal, E., Becker, B., Kieninger, D., Prymula, R., Dull, P., Ypma, E., Toneatto, D., Kimura, A., & Pollard, A. J. (2012). Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial. JAMA : the journal of the American Medical Association. https://doi.org/10.1001/jama.2012.85